Class information for:
Level 1: SUPLATAST TOSILATE//CX 659S//TH2 TYPE REACTION

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
34415 112 25.7 69%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
315 3       ALLERGY//MAST CELLS//BRADYKININ 39886
1331 2             ALLERGIC RHINITIS//ANTIHISTAMINES//ALLERGIC CONJUNCTIVITIS 8385
34415 1                   SUPLATAST TOSILATE//CX 659S//TH2 TYPE REACTION 112

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 SUPLATAST TOSILATE authKW 3207505 18% 59% 20
2 CX 659S authKW 1908475 6% 100% 7
3 TH2 TYPE REACTION authKW 545279 2% 100% 2
4 BIPHASIC CUTANEOUS REACTION authKW 490748 3% 60% 3
5 IPD 1151T SUPLATAST TOSILATE authKW 363518 2% 67% 2
6 1 BENZHYDRYLPIPERAZINE AMIDES authKW 272639 1% 100% 1
7 1 PHENYL 6 AMINOURACILS authKW 272639 1% 100% 1
8 2 4 DICHLORPHENOXYACETIC ACID AND 3 INDOLYLACETIC ACID authKW 272639 1% 100% 1
9 3 MORPHOLINOSYDONONIMINE N ETHYLCARBAMIDE authKW 272639 1% 100% 1
10 4 3 ETHOXY 2 HYDROXYPROPOXY ACRYLANILIDE authKW 272639 1% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Allergy 3198 25% 0% 28
2 Immunology 455 31% 0% 35
3 Pharmacology & Pharmacy 357 34% 0% 38
4 Chemistry, Medicinal 310 16% 0% 18
5 Dermatology 112 8% 0% 9
6 Respiratory System 72 7% 0% 8
7 Integrative & Complementary Medicine 49 3% 0% 3
8 Medicine, Research & Experimental 14 5% 0% 6
9 Chemistry, Multidisciplinary 9 9% 0% 10
10 Chemistry, Organic 7 5% 0% 6

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MED 377 2 272639 1% 100% 1
2 PEDIATSECT PULM 272639 1% 100% 1
3 UTC LUNG 272639 1% 100% 1
4 EDUC HOSP 2 155791 2% 29% 2
5 MEDSECT PULM 136319 1% 50% 1
6 NAT DRUG OURCES 136319 1% 50% 1
7 LOW DOSE RADIAT TEAM 54526 1% 20% 1
8 OIL CHEM CATALYSIS 54526 1% 20% 1
9 SERV INFORMAT DOCUMENTAZ BIBLIOTECA ATTIVITA ED 54526 1% 20% 1
10 P INFECT DISMIYAMAE KU 45438 1% 17% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 SPECTROSCOPY-BIOMEDICAL APPLICATIONS 4781 1% 2% 1
2 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 3156 6% 0% 7
3 CLINICAL AND EXPERIMENTAL ALLERGY 1937 5% 0% 6
4 FOLIA PHARMACOLOGICA JAPONICA 989 2% 0% 2
5 TRANSPLANT IMMUNOLOGY 956 2% 0% 2
6 SKIN PHARMACOLOGY 951 1% 0% 1
7 ALLERGOLOGY INTERNATIONAL 898 1% 0% 1
8 JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS 847 1% 0% 1
9 JOURNAL OF ASTHMA 814 3% 0% 3
10 ANNALI DELL ISTITUTO SUPERIORE DI SANITA 601 1% 0% 1

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 SUPLATAST TOSILATE 3207505 18% 59% 20 Search SUPLATAST+TOSILATE Search SUPLATAST+TOSILATE
2 CX 659S 1908475 6% 100% 7 Search CX+659S Search CX+659S
3 TH2 TYPE REACTION 545279 2% 100% 2 Search TH2+TYPE+REACTION Search TH2+TYPE+REACTION
4 BIPHASIC CUTANEOUS REACTION 490748 3% 60% 3 Search BIPHASIC+CUTANEOUS+REACTION Search BIPHASIC+CUTANEOUS+REACTION
5 IPD 1151T SUPLATAST TOSILATE 363518 2% 67% 2 Search IPD+1151T+SUPLATAST+TOSILATE Search IPD+1151T+SUPLATAST+TOSILATE
6 1 BENZHYDRYLPIPERAZINE AMIDES 272639 1% 100% 1 Search 1+BENZHYDRYLPIPERAZINE+AMIDES Search 1+BENZHYDRYLPIPERAZINE+AMIDES
7 1 PHENYL 6 AMINOURACILS 272639 1% 100% 1 Search 1+PHENYL+6+AMINOURACILS Search 1+PHENYL+6+AMINOURACILS
8 2 4 DICHLORPHENOXYACETIC ACID AND 3 INDOLYLACETIC ACID 272639 1% 100% 1 Search 2+4+DICHLORPHENOXYACETIC+ACID+AND+3+INDOLYLACETIC+ACID Search 2+4+DICHLORPHENOXYACETIC+ACID+AND+3+INDOLYLACETIC+ACID
9 3 MORPHOLINOSYDONONIMINE N ETHYLCARBAMIDE 272639 1% 100% 1 Search 3+MORPHOLINOSYDONONIMINE+N+ETHYLCARBAMIDE Search 3+MORPHOLINOSYDONONIMINE+N+ETHYLCARBAMIDE
10 4 3 ETHOXY 2 HYDROXYPROPOXY ACRYLANILIDE 272639 1% 100% 1 Search 4+3+ETHOXY+2+HYDROXYPROPOXY+ACRYLANILIDE Search 4+3+ETHOXY+2+HYDROXYPROPOXY+ACRYLANILIDE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 KUBOTA, K , KUREBAYASHI, H , MIYACHI, H , TOBE, M , ONISHI, M , ISOBE, Y , (2009) SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF PHENOTHIAZINE CARBOXYLIC ACIDS HAVING PYRIMIDINE-DIONE AS NOVEL HISTAMINE H-1 ANTAGONISTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 19. ISSUE 10. P. 2766 -2771 9 69% 15
2 YOSHIHARA, S , FUKUDA, H , ARISAKA, O , (2011) USEFULNESS OF SUPLATAST TOSILATE, A TH2 CYTOKINE INHIBITOR BASED ON THE TH1/TH2 RATIO FOR ALLERGIC DISEASE IN CHILDREN: A RETROSPECTIVE STUDY.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 61. ISSUE 7. P. 421 -424 6 100% 1
3 SHIMIZU, S , HATTORI, R , MAJIMA, Y , SHIMIZU, T , (2009) TH2 CYTOKINE INHIBITOR SUPLATAST TOSILATE INHIBITS ANTIGEN-INDUCED MUCUS HYPERSECRETION IN THE NASAL EPITHELIUM OF SENSITIZED RATS.ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY. VOL. 118. ISSUE 1. P. 67-72 10 48% 5
4 HORIGUCHI, T , TACHIKAWA, S , HANDA, M , HANAZONO, K , KONDO, R , ISHIBASHI, A , BANNO, K , (2001) EFFECTS OF SUPLATAST TOSILATE ON AIRWAY INFLAMMATION AND AIRWAY HYPERRESPONSIVENESS.JOURNAL OF ASTHMA. VOL. 38. ISSUE 4. P. 331-336 7 64% 13
5 TATSUMI, T , YAMADA, T , NAGAI, H , TERASAWA, K , TANI, T , NUNOME, S , SAIKI, I , (2001) A KAMPO FORMULATION: BYAKKO-KA-NINJIN-TO (BAI-HU-JIA-REN-SHENG-TANG) INHIBITS IGE-MEDIATED TRIPHASIC SKIN REACTION IN MICE: THE ROLE OF ITS CONSTITUENTS IN EXPRESSION OF THE EFFICACY.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 24. ISSUE 3. P. 284 -290 6 75% 5
6 TAN, YP , LI, Y , LIU, D , ZHONG, LL , (2013) SUPLATAST TOSILATE AMELIORATES AIRWAY HYPERREACTIVITY AND INFLAMMATION THROUGH INHIBITION OF THE GATA-3/IL-5 SIGNALING PATHWAY IN ASTHMATIC RATS.MOLECULAR MEDICINE REPORTS. VOL. 8. ISSUE 1. P. 161-167 10 31% 4
7 TADA, Y , YAMAWAKI, I , UEDA, S , MATSUMOTO, H , MATSUURA, N , YASUMOTO, M , KODA, A , HORI, M , (1998) SYNTHESIS AND ANTIALLERGIC ACTIVITY OF DIMETHYL-2-(PHENYLCARBAMOYL)ETHYLSULFONIUM P-TOLUENESULFONATE DERIVATIVES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 41. ISSUE 18. P. 3330 -3336 5 83% 2
8 SANO, T , NAKAMURA, Y , YANAGAWA, H , BANDO, H , NII, A , YOSHIDA, S , SONE, S , (2003) ADD-ON EFFECTS OF SUPLATAST TOSILATE IN BRONCHIAL ASTHMA PATIENTS TREATED WITH INHALED CORTICOSTEROIDS.LUNG. VOL. 181. ISSUE 4. P. 227-235 8 36% 2
9 MIYAKE, I , NABE, T , YAMAMURA, H , KOHNO, S , (2000) REPRODUCIBLE BIPHASIC CUTANEOUS EDEMA INDUCED BY TOPICAL AND REPEATED APPLICATION OF ANTIGEN IN SENSITIZED MICE.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 23. ISSUE 4. P. 432 -437 5 56% 0
10 NAGAI, H , (2012) RECENT RESEARCH AND DEVELOPMENTAL STRATEGY OF ANTI-ASTHMA DRUGS.PHARMACOLOGY & THERAPEUTICS. VOL. 133. ISSUE 1. P. 70 -78 14 13% 11

Classes with closest relation at Level 1



Rank Class id link
1 29170 OXATOMIDE//ZWITTER IONIZATION//DEV MED 1
2 26417 AZELASTINE//CAS 58581 89 8//ALLERGODILR
3 37587 IBUDILAST//CAS 50847 11 5//3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY
4 5436 INTERLEUKIN 5//IL 5//EOSINOPHILS
5 11520 ATOPIC DERMATITIS//ATOPY PATCH TEST//NC NGA MICE
6 33455 EARLY TYPE HYPERSENSITIVITY//ANTI MOUSE GRANULOCYTE ANTIBODY//WBB6F1 W W V
7 24406 EPICUTANEOUS IMMUNIZATION//HUMAN DEV BIOL//CONTRASUPPRESSION
8 10454 OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E
9 24946 HISTAMINE H 1 RECEPTOR//MOL STUDIES INCURABLE DIS//H 3 MEPYRAMINE
10 33213 PLANT MITOGENS//PHA L4//MITOGENIC LECTINS

Go to start page